Zylox-Tonbridge Medical Technology Co (HKSE:02190) Cash And Cash Equivalents : HK$1,188.5 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co Cash And Cash Equivalents?

Zylox-Tonbridge Medical Technology Co's quarterly cash and cash equivalents increased from Dec. 2022 (HK$1,345.98 Mil) to Jun. 2023 (HK$1,429.43 Mil) but then stayed the same from Jun. 2023 (HK$1,429.43 Mil) to Dec. 2023 (HK$1,188.48 Mil).

Zylox-Tonbridge Medical Technology Co's annual cash and cash equivalents declined from Dec. 2021 (HK$1,736.73 Mil) to Dec. 2022 (HK$1,345.98 Mil) and declined from Dec. 2022 (HK$1,345.98 Mil) to Dec. 2023 (HK$1,188.48 Mil).

Zylox-Tonbridge Medical Technology Co Cash And Cash Equivalents Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co Cash And Cash Equivalents Chart

Zylox-Tonbridge Medical Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

51.33

70.60

1,736.73

1,345.98

1,188.48

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial				1,736.73	1,239.11	1,345.98	1,429.43	1,188.48

Zylox-Tonbridge Medical Technology Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Zylox-Tonbridge Medical Technology Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 Keji Avenue, Yuhang Street, 1st & 2nd Floors, Building 1, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.zyloxtb.com

Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries.

Executives

Gan Zhou Ti Tan Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2501 Other
Su Zhou Tai Hong Jing Hui Tou Zi Zhong Xin You Xian He Huo	2501 Other
Five Investment Limited	2501 Other
Highlight Medical Limited	2501 Other
Ourea Biotech Hk Limited	2501 Other
Wang Stephen Hui	2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Tie Si Yi Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2501 Other
Jia Jian Tou Zi You Xian Gong Si	2501 Other
Wea Enterprises ,llc	2401 A concert party to an agreement to buy shares
Hu Zhou Yu Yi Hui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Ning Bo Gui Qiao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhu Hai Gui Chuang Gu Quan Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Hang Zhou Fu Jiang Tou Zi He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhu Hai Tong Qiao Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Li Zheng	2501 Other

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Headlines

No Headlines